Clinical Trial Update: Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing laser therapy plus intravitreal aflibercept versus intravitreal aflibercept alone for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Aflibercept (Aflibercept)
• Laser therapy

Snippet

Sponsor: University of Sydney | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED